Catalyst Wire Dossier Catalyst Wire Dossier

Bexmarilimab

Bexmarilimab
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bexmarilimab, covering 2026-03-10 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies [Phase 1, Phase 2]

See pricing